Lind Global Fund II LP 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:08 pm Unchanged | 2025-12-31 | 13G | Tenax Therapeutics, Inc. TENX | Lind Global Fund II LP | 442,480 6.620% | 0 (Unchanged) | Filing |
| 2025-11-14 4:10 pm Purchase | 2025-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Lind Global Fund II LP | 442,480 8.800% | 67,480 (+17.99%) | Filing |
| 2024-11-14 7:14 pm Purchase | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Lind Global Fund II LP | 375,000 9.900% | 375,000 (New Position) | Filing |